Theravance Biopharma (TBPH) Highlights Submission of IMPACT Data to EMA to Support Expanded Label for Trelegy Ellipta
Tweet Send to a Friend
Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") today highlighted the submission of the landmark IMPACT study data to the European ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
